Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026

Buy USD 20,000 Worth Of Reports (Single User/Multi User License) In USD 8000 Only

“Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026” Report highlights:

Europe Biosimilars Market Opportunity: > USD 10 Billion
Dosage and Pricing insight On Approved Biosimilars
Biosimilars for Cancers Accounts for > 20% Market
Biosimilars for Diabetes Accounts for > 5% Market
Biosimilars Approval and Commercialization by Country
Insight On Biosimilar Clinical Trials By Company, Indication and Phase: > 100 Biosimilars
Insight On Commercially available Biosimilars in Market: > 25 Biosimilars
Biosimilar Market Trends by Country

Biopharmaceutical drugs have become an important part of modern pharmacotherapy. In recent times, biological drugs have comprised about 50% of the overall therapeutic market owing to their high efficacy and specificity in the management of wide range of diseases. However, the high cost of treatment associated with them possesses a significant burden on the healthcare systems. The patent expiration of the biologic drugs has led to the development of biosimilar which aim to reduce the cost of treatment thus increasing the accessibility of the medications to the patients.

Presently, there are 69 biosimilars in Europe which have been approved in clinic for the wide range of diseases including arthritis, cancer, inflammatory and auto-immune disorders. The European biosimilar market was the first to be established and still represents the most mature and advancing market at a global scale owing to the large number of approved and commercially avialable biosimilars. Adalimumab (Humira) is currently dominating the market which is due to high adoption rates of this drug associated with large number of biosimilar approval. Apart from this, several biosimilars for one reference product has been approved which increases the competition in the market. Adalimumab faces majority of competition with 6 biosimilars approved followed by Trastuzumab and Mabthera with five biosimilars competing with the reference product in the market.

Since the launch of first biosimilar in Europe, the biosimilar market is continuously evolving and showing high adoption rates. The region represents an excellent market for the growth of biosimilars due to the presence of large pharmaceutical sector which actively indulge in research and development activities. The biosimilar market in Europe is highly competitive, with many key players dominating the market landscape including Novartis, Celltrion, Accord Healthcare, Pfizer and Mylan. Most of the key players are adopting various growth strategies, such as acquisitions, partnerships and new product launches to increase their revenue.

Currently, the market is mainly dominated by UK which is mainly due to technological advancements in the healthcare care and healthcare spending. Regions including Denmark, Italy, France, and Germany are other lucurative markets and are expected high growth rates during the forecast period. Among the European countries, Denamrk has been outstanding for its biosimilar consumption. Moreover, Denmark has also implemented one of the most radical biosimilar programs and produced a considerable amount of share in the overall biosimilar volume.

As per “Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026” report findings, the Europe biosimilar market opportunity is expected to surpass US$ 10 10 Billion by 2026. The high rate in the market is mainly due to the rising demand for biosimilars due to their cost saving potential. In addition, the rising geriatric population in the region is also boosting the growth of European Biosimilar market. Moreover, an increase in burden on lifestyle diseases and the proliferation of chronic diseases including diabetes, cancer, asthma, arthritis and others, influence the biosimilar market during the forecast period. Furthermore, in coming years the patent of several drugs including Cimzia, Yervoy, Lemtrada, Lucentis and others are expected to expire during the forecast period, which will further propel the development of biosimilars in Europe.

Introduction To Europe Biosimilar Market

Development of Biosimilars in Europe

2.1 Development of First Biosimilar Omnitrope: Genotropin

2.2 Second Wave of Biosimilars Development in Europe

Significance of Biosimilars in Europe Pharmaceutical Market

Off Patents: Biosimilar Opportunity Ahead

Europe Biosimilars Approval and Commercialization by Country

EMA Approved and Marketed Cancer Biosimilars: Dosage and Price Analysis

6.1 Biosimilars of Bevacizumab

6.2 Biosimilar to MabThera

6.3 Biosimilar of Trastuzumab

EMA Approved and Marketed Biosimilars in Blood Disorders: Dosage and Price Analysis

7.1 Biosimilar of Filgrastim

7.2 Biosimilar of Pegfilgrastim

7.3 Biosimilar of Enoxaparin Sodium

EMA Approved and Marketed Biosimilars in Diabetes: Dosage and Price Analysis

8.1 Biosimilar of Insuling Glargine

8.2 Biosimilar of Insulin Aspartate

8.3 Biosimilar of Insulin Lispro

EMA Approved and Marketed Biosimilars in Chronic Autoimmune Diseases: Dosage and Price Analysis

9.1 Biosimilar of Adalimumab

9.2 Biosimilar of Etanercept

9.3 Biosimilar of Infliximab

EMA Approved and Marketed Biosimilars in Other Therapeutic Indications: Dosage and Price Analysis

10.1 Biosimilar of Teriparatide

10.2 Biosimilar of Somatropin

10.3 Biosimilar of Follitropin Alfa

10.4 Biosimilar of Epoetin Alfa

Europe Biosimilar Market Insight

11.1 Market Overview

11.2 Current Market Scenario

Europe Biosimilar Market by Indication

12.1 Cancer

12.2 Autoimmune Diseases

12.3 Diabetes

12.4 Blood Disorders

Europe Biosimilar Clinical Trials By Company, Indication and Phase

13.1 Unknown

13.2 Research

13.3 Clinical

13.4 Phase-I

13.5 Phase-III

13.6 Preregistration

13.7 Registered

Europe Marketed Biosimilar Clinical Insight By Company, Drug Class and Indication

European Biosimilar Market Trends by Country

15.1 Austria

15.2 Belgium

15.3 Hungary

15.4 Italy

15.5 Norway

15.6 Poland

15.7 Spain

15.8 Sweden

15.9 Switzerland

15.10 UK

15.11 Germany

15.12 France

15.13 Denmark

Europe Vs. Global Biosimilar Market Scenarios

16.1 Europe vs. US Biosimilar Market

16.2 Europe vs. India Biosimilar Market

16.3 Europe vs. China Biosimilar Market

16.4 Europe vs. Japan Biosimilar Market

16.5 Europe vs. South Korea Biosimilar Market

Europe Biosimilar Market Dynamics

17.1 Favorable Market Parameters

17.2 Europe Biosimilar Market Challenges

Europe Biosimilar Market Future Prospects

Competitive Landscape

19.1 Accord Healthcare

19.2 Amgen

19.3 AstraZeneca

19.4 Boehringer Ingelheim

19.5 Eli Lilly and Company

19.6 Merck

19.7 Mylan Pharmaceuticals

19.8 Novartis

19.9 Pfizer

19.10 Sanofi

19.11 Takeda Pharmaceuticals

19.12 Teva Pharmaceutical

Figure 1-1: Europe – Approved Biosimilars by Indication

Figure 2-1: Early Development of First Biosimilar in Europe

Figure 2-2: EMA Approved Biosimilars, 2016-2020

Figure 2-3: EMA Approved Biosimilars by Reference Product’2021

Figure 2-4: EMA Approved Biosimilars by Therapeutic Indication, 2021

Figure 3-1: Significance of Biosimilars in Europe Biopharmaceutical Market

Figure 4-1: Europe – Ipilimumab EU Approval and Patent Expiration Year

Figure 4-2: Europe – Alemtuzumab EU Approval and Patent Expiration Year

Figure 4-3: Europe – Ranibizumab EU Approval and Patent Expiration Year

Figure 4-4: Europe – Ustekinumab EU Approval and Patent Expiration Year

Figure 4-5: Europe – Denosumab EU Approval and Patent Expiration Year

Figure 5-1: Europe – Biosimilars Approved in Different Therapeutic Class

Figure 6-1: Bevacizumab – Branded and Biosimilar EMA Approval Year

Figure 6-2: UK – Cost of 4ml Aybintio 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-3: UK – Cost of 16ml Aybintio 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-4: Denmark – Cost of 4ml Aybintio 100mg/4ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-5: Denmark – Cost of 16ml Aybintio 400mg/16ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-6: Netherlands – Cost of 4ml Aybintio 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-7: Netherlands – Cost of 16ml Aybintio 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-8: Germany – Cost of 4ml Aybintio 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-9: Germany – Cost of 16ml Aybintio 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-10: Germany – Cost of 4ml Mvasi 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-11: Germany – Cost of 16ml Mvasi 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-12: Denmark – Cost of 4ml Mvasi 100mg/4ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-13: Denmark – Cost of 16ml Mvasi 400mg/16ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-14: Netherlands – Cost of 4ml Mvasi 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-15: Netherlands – Cost of 16ml Mvasi 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-16: UK – Cost of 4ml Zirabev 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-17: UK – Cost of 16ml Zirabev 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-18: Denmark – Cost of 4ml Zirabev 100mg/4ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-19: Denmark – Cost of 16ml Zirabev 400mg/16ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-20: Netherlands – Cost of 4ml Zirabev 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-21: Netherlands – Cost of 16ml Mvasi 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-22: Germany – Cost of 4ml Zirabev 100mg/4ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-23: Germany – Cost of 16ml Zirabev 400mg/16ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-24: Bevacizumab – Recommended Initial Dose by Cancer Types (mg/kg)

Figure 6-25: MabThera – Branded and Biosimilar EMA Approval Year

Figure 6-26: UK – Cost of 50ml Truxima 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-27: UK – Cost of 2 Vials of Truxima 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-28: Germany – Cost of 50ml Truxima 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-29: Germany – Cost of 2 Vials of Truxima 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-30: Netherlands – Cost of 50ml Truxima 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-31: Netherlands – Cost of 50ml Truxima 100mg/10ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-32: UK – Cost of 2 Vials of Rixathon 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-33: UK – Cost of 2 Vials of Rixathon 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-34: Germany – Cost of 2 Vials of Rixathon 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-35: Germany – Cost of 2 Vials of Rixathon 100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-36: Netherlands – Cost of 50ml Rixathon500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-37: Netherlands – Cost of 50ml Rixathon100mg/10ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-38: Denmark– Cost of 50ml Rixathon500mg/50ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-39: Denmark – Cost of 2 Vials of Rixathon 100mg/10ml Solution and Per Unit Cost of Vial (DKK/US$), July’2021

Figure 6-40: Germany – Cost of 50ml Blitzima 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-41: Germany – Cost of 2 Vials of Blitzima100mg/10ml Solution and Per Unit Cost of Vial (Euro/US$), July’2021

Figure 6-42: Denmark– Cost of 50ml Ritemvia 500mg/50ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-43: Denmark – Cost of 2 Vials of Ritemvia 100mg/10ml Solution and Per Unit Cost of Vial (DKK/US$), July’2021

Figure 6-44: Netherlands – Cost of 50ml Ruxience 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-45: Netherlands – Cost of 50ml Ruxience 100mg/10ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-46: Germany – Cost of 50ml Ruxience 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-47: Germany – Cost of 50ml Ruxience 100mg/10ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-48: UK – Cost of 50ml Ruxience 500mg/50ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-49: UK – Cost of 10ml Ruxience 100mg/10ml Solution and Per Unit Cost of Solution (Euro/US$), July’2021

Figure 6-50: Denmark – Cost of 50ml Ruxience 500mg/50ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-51: Denmark – Cost of 10ml Ruxience 100mg/10ml Solution and Per Unit Cost of Solution (DKK/US$), July’2021

Figure 6-52: Trastuzumab – Branded and Biosimilar EMA Approval Year

Figure 6-53: UK – Cost of Ontruzant 150mg Powder (Euro/US$), July’2021

Figure 6-54: Denmark – Cost of Ontruzant 420mg Powder (DKK/US$), July’2021

Figure 6-55: Germany – Cost of 150mg and 420mg Ontruzant Powder (Euro/US$), July’2021

Figure 6-56: Netherlands – Cost of 150mg and 420mg Ontruzant Powder (Euro/US$), July’2021

Figure 6-57: UK – Cost of 150mg and 420mg Herzuma Powder (Euro/US$), July’2021

Figure 6-58: Germany – Cost of 150mg and 420mg Herzuma Powder (Euro/US$), July’2021

Figure 6-59: Netherland – Cost of 150mg and 420mg Herzuma Powder (Euro/US$), July’2021

Figure 6-60: UK – Cost of 150mg and 420mg Trazimera Powder (Euro/US$), July’2021

Figure 6-61: Netherland – Cost of 150mg and 420mg Trazimera Powder (Euro/US$), July’2021

Figure 6-62: Germany – Cost of 150mg and 420mg Trazimera Powder (Euro/US$), July’2021

Figure 6-63: Denmark – Cost of 150mg and 420mg Trazimera Powder (DKK/US$), July’2021

Figure 6-64: UK – Cost of 150mg and 420mg Kanjinti Powder (Euro/US$), July’2021

Figure 6-65: Germany – Cost of 150mg and 420mg Herzuma Powder (Euro/US$), July’2021

Figure 6-66: Netherland – Cost of 150mg and 420mg Kanjinti Powder (Euro/US$), July’2021

Figure 6-67: UK – Cost of Zercepac 150mg Powder (Euro/US$), July’2021

Figure 6-68: Germany – Cost of Zercepac 150mg Powder (Euro/US$), July’2021

Figure 6-69: Netherland – Cost of Zercepac 150mg Powder (Euro/US$), July’2021

Figure 6-70: Trastuzumab – Recommended Initial and Maintenance Dose by Cancer Types (mg/kg)

Figure 7-1: Filgrastim – Biosimilar EMA Approval Year by Brand

Figure 7-2: Germany – Cost of 5 Pre-Filled Ratiograstim 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-3: Germany – Cost of 5 Pre-Filled Ratiograstim 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-4: Germany – Cost of 5 Pre-Filled Tevagrastim 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-5: Germany – Cost of 5 Pre-Filled Tevagrastim 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-6: Netherland – Cost of Per Unit Pre-Filled Tevagrastim Disposable Pen by Strength (Euro/US$), July’2021

Figure 7-7: Germany – Cost of 5 Pre-Filled Filgrastim Hexal 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-8: Germany – Cost of 5 Pre-Filled Filgrastim Hexal 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-9: UK – Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-10: UK – Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-11: Germany – Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-12: Germany – Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-13: Netherland – Cost of Per Unit Pre-Filled Zarzio Disposable Pen by Strength (Euro/US$), July’2021

Figure 7-14: Denmark – Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen and Per Unit Price of Pen (DKK/US$), July’2021

Figure 7-15: Denmark – Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen and Per Unit Price of Pen (DKK/US$), July’2021

Figure 7-16: UK – Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-17: UK – Cost of 5 Pre-Filled Nivestim 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-18: UK – Cost of 5 Pre-Filled Nivestim 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-19: Germany – Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-20: Germany – Cost of 5 Pre-Filled Nivestim 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-21: Germany – Cost of 5 Pre-Filled Nivestim 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-22: Denmark – Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen and Per Unit Price of Pen (DKK/US$), July’2021

Figure 7-23: Netherland – Cost of Per Unit Pre-Filled Nivestim Disposable Pen by Strength (Euro/US$), July’2021

Figure 7-24: Germany – Cost of 5 Pre-Filled Grastofil 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-25: Germany – Cost of 5 Pre-Filled Grastofil 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-26: UK – Cost of 7, 5 Pre-Filled Nivestim 30 million units/0.5ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-27: UK – Cost of 7, 5 Pre-Filled Nivestim 48 million units/0.8ml Pen and Per Unit Price of Pen (Euro/US$), July’2021

Figure 7-28: Denmark – Cost of 5 Pre-Filled Accofil 30 million units/0.5ml Pen and Per Unit Price of Pen (DKK/US$), July’2021

Figure 7-29: Denmark – Cost of 5 Pre-Filled Accofil 48 million units/0.8ml Pen and Per Unit Price of Pen (DKK/US$), July’2021

Figure 7-30: Netherland – Cost of Per Unit Pre-Filled Accofil Disposable Pen by Strength (Euro/US$), July’2021

Figure 7-31: Filgrastim – Recommended Initial Dose by Indication (mcg/kg/day)

Figure 7-32: Filgrastim – Recommended Minimum and Maximum Dose for Congenital Neutropenia (mcg/kg/day)

Figure 7-33: Pegfilgrastim – Biosimilar EMA Approval Year by Brand

Figure 7-34: UK – Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021

Figure 7-35: Denmark – Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (DKK/US$), July’2021

Figure 7-36: Germany – Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021

Figure 7-37: Netherlands – Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021

Figure 7-38: Denmark – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (DKK/US$), July’2021

Figure 7-39: UK – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (Euro/US$), July’2021

Figure 7-40: Germany – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (Euro/US$), July’2021

Figure 7-41: Netherlands – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (Euro/US$), July’2021

Figure 7-42: UK – Cost of 0.6ml Pre-Filled Pelmeg Pen and Per Unit (Euro/US$), July’2021

Figure 7-43: Netherlands – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (Euro/US$), July’2021

Figure 7-44: Germany – Cost of 0.6ml Pre-Filled Ziextenzo Pen and Per Unit (Euro/US$), July’2021

Figure 7-45: Germany – Cost of 0.6ml Pre-Filled Grastutek Pen and Per Unit (Euro/US$), July’2021

Figure 7-46: Germany – Cost of 0.6ml Pre-Filled Cegfila Pen and Per Unit (Euro/US$), July’2021

Figure 7-47: Germany – Cost of 0.6ml Pre-Filled Nyvepria Pen and Per Unit (Euro/US$), July’2021

Figure 7-48: Pegfilgrastim – Recommended Dose for Pediatric Patients with Neutropenia (mcg/kg/day)

Figure 7-49: UK – Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021

Figure 7-50: Netherlands – Average Price Per Piece of Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021

Figure 7-51: Germany – Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021

Figure 7-52: Germany – Cost of 12 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021

Figure 7-53: Denmark – Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021

Figure 7-54: Enoxaparin Sodium – Recommended Dose for Management of Myocardial Infarction by Age (mg/kg/day)

Figure 7-55: Enoxaparin Sodium – Recommended Pediatric Dose for Management of Deep Vein Thrombosis by Age (mg/kg/day)

Figure 7-56: Enoxaparin Sodium – Recommended Pediatric Dose for Management of Prophylaxis by Age (mg/kg/day)

Figure 8-1: Insulin Glargine: Branded and Biosimilar EMA Approval Year

Figure 8-2: Denmark - Cost of Abasaglar 5 Cartridges and Per Unit Price of 100Units/ml Cartridge (DKK/US$), July'2021

Figure 8-3: UK - Cost of Abasaglar 5 Cartridges and Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021

Figure 8-4: Germany - Cost of Abasaglar 5 Cartridges and Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021

Figure 8-5: Germany - Cost of Abasaglar 10 Cartridges and Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021

Figure 8-6: Netherlands - Cost of Per Unit Price of Abasaglar 100Units/ml Cartridge (Euro/US$), July'2021

Figure 8-7: Denmark - Cost of Semglee 5 Cartridges and Per Unit Price of 100Units/ml Cartridge (DKK/US$), July'2021

Figure 8-8: UK - Cost of Semglee Pre-Filled Pens and Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021

Figure 8-9: Insulin Aspartate: Branded and Biosimilar EMA Approval Year

Figure 8-10: Denmark - Cost of 5 Insulin Aspart Pens and Per Unit Price of 100Units/ml Pen (DKK/US$), July'2021

Figure 8-11: Germany - Cost of 10 Insulin Aspart Pens and Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021

Figure 8-12: Insulin Lispro: Branded and Biosimilar EMA Approval Year

Figure 8-13: UK - Cost of 5 Lyumjev Pens and Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021

Figure 8-14: UK - Cost of 5 Lyumjev Pens and Per Unit Price of 200Units/ml Pen (Euro/US$), July'2021

Figure 8-15: Germany - Cost of 5 Lyumjev Pens and Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021

Figure 8-16: Germany - Cost of 5 Lyumjev Pens and Per Unit Price of 200Units/ml Pen (Euro/US$), July'2021

Figure 9-1: Adalimumab: Branded and Biosimilar EMA Approval Year

Figure 9-2: Denmark - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution DKK/US$), July'2021

Figure 9-3: Denmark - Cost of 2 Pre-Filled Amgevita 40mg Injection and Per Unit Price of Injectable Solution (DKK/US$), July'2021

Figure 9-4: Germany - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021

Figure 9-5: Germany - Cost of 2 Pre-Filled Amgevita 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-6: Germany - Cost of 6 Pre-Filled Amgevita 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-7: UK - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021

Figure 9-8: UK - Cost of 2 Pre-Filled Amgevita 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-9: Netherlands - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021

Figure 9-10: Netherlands - Cost of Per Unit Amgevita 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-11: Germany - Cost of 2 Pre-Filled Hulio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-12: Germany - Cost of 6 Pre-Filled Hulio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-13: UK - Cost of 2 Pre-Filled Hulio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-14: Netherlands - Cost of Per Unit Hulio 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-15: Germany - Cost of 2 Pre-Filled Hyrimoz 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-16: Germany - Cost of 6 Pre-Filled Hyrimoz 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-17: UK - Cost of 2 Pre-Filled Hyrimoz 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-18: Denmark- Cost of 2 Pre-Filled Hyrimoz 40mg Injection and Per Unit Price of Injectable Solution (DKK/US$), July'2021

Figure 9-19: Netherlands - Cost of Per Unit Hyrimoz 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-20: Netherlands - Cost of Per Unit Hyrimoz 20mg/0.4ml Injectable Solution (Euro/US$), July'2021

Figure 9-21: Germany - Cost of 2 Pre-Filled Idacio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-22: Germany - Cost of 6 Pre-Filled Idacio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-23: UK - Cost of 2 Pre-Filled Idacio 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-24: Netherlands - Cost of Per Unit Idacio 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-25: Germany - Cost of 2 Pre-Filled Yuflyma 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-26: Germany - Cost of 6 Pre-Filled Yuflyma 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-27: Netherlands - Cost of Per Unit Yuflyma 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-28: UK - Cost of 2 Pre-Filled Imraldi 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-29: Germany - Cost of 2 Pre-Filled Imraldi 40mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-30: Netherlands - Cost Per Unit Price of Imraldi 40mg/0.8ml Injectable Solution (Euro/US$), July'2021

Figure 9-31: Denmark - Cost of 2 Pre-Filled Imraldi 40mg Injection and Per Unit Price of Injectable Solution (DKK/US$), July'2021

Figure 9-32: Adalimumab - Recommended Dose for Adult Patients with Crohn's Disease, Hidradenitis Suppurativa and Ulcerative Colitis (mg)

Figure 9-33: Adalimumab - Recommended Dose for Adult Patients with Plaque Psoriasis and Uvetis (mg)

Figure 9-34: Adalimumab - Recommended Dose for Pediatric Patients with Juvenile Idiopathic Arthritis and Uvetis by Weight (mg)

Figure 9-35: Adalimumab - Recommended Dose for Pediatric Patients with Crohn's Disease, by Weight (mg)

Figure 9-36: Etanercept: Branded and Biosimilar Approval Year

Figure 9-37: UK - Cost of 4 Pre-Filled Benepali 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-38: UK - Cost of 4 Pre-Filled Benepali 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-39: Germany - Cost of 24 Pre-Filled Benepali 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-40: Germany - Cost of 4 Pre-Filled Benepali 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-41: Netherlands - Cost Per Unit Price of Benepali 50mg Injectable Solution (Euro/US$), July'2021

Figure 9-42: Denmark - Cost of 4 Pre-Filled Benepali 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-43: Denmark - Cost of 4 Pre-Filled Benepali 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-44: UK - Cost of 4 Pre-Filled Erelzi 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-45: UK - Cost of 4 Pre-Filled Erelzi 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-46: Germany - Cost of 4 Pre-Filled Erelzi 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-47: Germany - Cost of 4 Pre-Filled Erelzi 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-48: Netherlands - Cost Per Unit Price of Erelzi 50mg Injectable Solution (Euro/US$), July'2021

Figure 9-49: Denmark - Cost of 2 Pre-Filled Erelzi 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-50: Denmark - Cost of 4 Pre-Filled Erelzi 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-51: Germany - Cost of 4 Pre-Filled Nepexto 25mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-52: Germany - Cost of 4 Pre-Filled Nepexto 50mg Injection and Per Unit Price of Injectable Solution (Euro/US$), July'2021

Figure 9-53: Etanercept - Recommended Initial Dose by Indication (mg/weekly)

Figure 9-54: Infliximab: Branded and Biosimilar Approval Year

Figure 9-55: UK - Cost of 2 Remsima Vials and Per Unit Price of 120mg Vial (Euro/US$), July'2021

Figure 9-56: Netherlands – Average Per Unit Price of Remsima Vials by Strength (Euro/US$), July'2021

Figure 9-57: Germany - Cost of 2 Remsima Vials and Per Unit Price of 100mg Vial (Euro/US$), July'2021

Figure 9-58: Germany - Cost of 2 Remsima Vials and Per Unit Price of 120mg Vial (Euro/US$), July'2021

Figure 9-59: Inflectra – Average Price Per Unit of 100mg Inflectra by Region (Euro/US$), July'2021

Figure 9-60: Flixabi – Average Price Per Unit of 100mg Flixabi by Region (Euro/US$), July'2021

Figure 9-61: Denmark - Cost of 3 Flixabi Vials and Per Unit Price of 120mg Vial (DKK/US$), July'2021

Figure 9-62: Zessly – Average Price Per Unit of 100mg Zessly by Region (Euro/US$), July'2021

Figure 9-63: Denmark - Cost of 3 ZesslyVials and Per Unit Price of 100mg Vial (DKK/US$), July'2021

Figure 9-64: Infliximab - Recommended Initial Dose by Indication (mg/kg)

Figure 10-1: Teriparatide – Branded and Biosimilar EMA Approval Year

Figure 10-2: UK – Cost of 3 Terrosa 2.4ml Cartridges and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-3: Germany – Cost of 3 Terrosa 2.4ml Cartridges and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-4: Denmark – Cost of Terrosa 2.4ml Cartridges and Per Unit Price of Solution (DKK/US$), July’2021

Figure 10-5: UK – Cost of Movymia 2.4ml Cartridges and Per Unit Price of Solution (Euro/US$), July’2021

Figure 10-6: Netherland – Cost of Movymia 2.4ml Cartridges and Per Unit Price of Solution (Euro/US$), July’2021

Figure 10-7: Germany – Cost of Movymia 2.4ml Cartridges and Per Unit Price of Solution (Euro/US$), July’2021

Figure 10-8: Denmark – Cost of Movymia 2.4ml Cartridges and Per Unit Price of Solution (DKK/US$), July’2021

Figure 10-9: Germany – Cost of Livogiva 2.4ml Cartridges and Per Unit Price of Solution (Euro/US$), July’2021

Figure 10-10: Teriparatide – Recommended Daily, Monthly and Annual Dose for Osteoporosis (mcg)

Figure 10-11: Somatropin – Branded and Biosimilar EMA Approval Year

Figure 10-12: UK – Cost of 5 Omnitrope Cartridge of 5mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-13: UK – Cost of 5 Omnitrope Cartridge of 10mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-14: UK – Cost of 5 Omnitrope Cartridge of 15mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-15: Germany – Cost of 5 Omnitrope Cartridge of 5mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-16: Germany – Cost of 5 Omnitrope Cartridge of 10mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-17: Germany – Cost of 5 Omnitrope Cartridge of 15mg/1.5ml and Per Unit Price of Cartridge (Euro/US$), July’2021

Figure 10-18: Netherlands – Average Price Per Unit of Omnitrope Cartridge by Strength (Euro/US$), July’2021

Figure 10-19: Denmark – Cost of 5 Omnitrope Cartridge of 5mg/1.5ml and Per Unit Price of Cartridge (DKK/US$), July’2021

Figure 10-20: Denmark – Cost of 5 Omnitrope Cartridge of 10mg/1.5ml and Per Unit Price of Cartridge (DKK/US$), July’2021

Figure 10-21: Denmark – Cost of 5 Omnitrope Cartridge of 15mg/1.5ml and Per Unit Price of Cartridge (DKK/US$), July’2021

Figure 10-22: Somatropin – Recommended Pediatric Dose by Indication (mg/kg/week)

Figure 10-23: Somatropin – Recommended Minimum and Maximum Dose for Growth Hormone Deficiency by Age (mg/kg/week)

Figure 10-24: Follitropin – Branded and Biosimilar EMA Approval Year

Figure 10-25: UK – Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-26: Netherland – Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-27: Germany – Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-28: UK – Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-29: Netherland – Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-30: Germany – Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-31: Denmark – Cost Per Unit of Ovaleap Pre-filled Pens by Strength (DKK/US$), July'2021

Figure 10-32: Follitropin Alfa - Recommended Minimum and Maximum Dose (IU/day)

Figure 10-33: Germany – Cost of 6 Abseamed Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-34: Netherlands – Average Cost Per Unit of Binocrit Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-35: Germany – Average Cost Per Unit of Epoetin Alfa Hexal Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-36: Germany – Cost of 6 Retacrit Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-37: UK– Cost of 6 Retacrit Pre-filled Pens by Strength (Euro/US$), July'2021

Figure 10-38: Epoetin Alfa – Recommended Initial Adult Dose for Anemia by Combination (units/kg)

Figure 10-39: Epoetin Alfa – Recommended Initial Pediatric Dose for Anemia by Combination (units/kg)

Figure 11-1: Europe - Geriatric Population (Million), 2019 and 2050

Figure 11-2: Europe - Approved Biosimilars by Status (%), July’2021

Figure 11-3: Europe - Biosimilar Market Size (US$ Billion), 2020-2026

Figure 12-1: US – Cancer Incidence and Mortality (Million), 2020 and 2040

Figure 12-2: Europe - Approved and Marketed Biosimilar by Indication (%), July’2021

Figure 12-3: Europe - Biosimilar Market Size by Indication (%), July’2021

Figure 12-4 Europe - Cancer Biosimilar Market Size (US$ Billion), 2020-2026

Figure 12-5: Europe - Approved and Marketed Biosimilar by Indication (%), July’2021

Figure 12-6: Europe - Biosimilar Market Size by Indication (%), July’2021

Figure 12-7: Europe - Autoimmune Diseases Biosimilar Market Size (US$ Billion), 2020-2026

Figure 12-8: Europe - Approved and Marketed Biosimilar by Indication (%), July’2021

Figure 12-9: Europe - Biosimilar Market Size by Indication (%), July’2021

Figure 12-10: Europe - Diabetes Biosimilar Market Size (US$ Billion), 2020-2026

Figure 12-11: Europe - Approved and Marketed Biosimilar by Indication (%), July’2021

Figure 12-12: Europe - Biosimilar Market Size by Indication (%), July’2021

Figure 12-13: Europe - Blood Disorder Biosimilar Market Size (US$ Million), 2020-2026

Figure 13-1: Europe – Number of Biosimilars in Clinical Trials by Phase, 2021 till 2026

Figure 13-2: Europe – Number of Biosimilars in Clinical Trials by Company, 2021 till 2026

Figure 13-3: Europe – Number of Biosimilars in Clinical Trials by Indication, 2021 till 2026

Figure 13-4: Europe – Number of Biosimilars in Clinical Trials by Patient Segment, 2021 till 2026

Figure 15-1: Belgium - Biosimilars Market Share by Volume, 2019

Figure 15-2: Spain - Cumulative Savings by Biosimilar (Euro/US$ Million), 2009-2019

Figure 15-3: UK - Cancer Biosimilar Market Size (US$ Million), 2020-2026

Figure 15-4: Germany – Cost Saving Potential of Biosimilar by Product (US$ Million), 2020

Figure 15-5 - France: Causes of Mortality by Gender (%), 2020

Figure 15-6: France - Biosimilar Market Size (US$ Million), 2020-2026

Figure 16-1: Approved Biosimilars - Europe vs. US

Figure 16-2: Approved and Marketed Biosimilar - Europe vs. US

Figure 16-3: Biosimilars Approved for Product - Europe vs. US

Figure 16-4: US – Biosimilar Market Size (US$ Billion), 2020-2026

Figure 16-5: Approved Biosimilar - Europe vs. India

Figure 16-6: First Approved Biosimilar - Europe vs. India

Figure 16-7: India – Biosimilar Clinical Pipeline by Status, 2019

Figure 16-8: India – Biosimilar Clinical Pipeline by Status (%), 2019

Figure 16-9: China – Biological Drugs Market Size (US$/Yuan Billion), 2020-2026

Figure 16-10: Approved Biosimilars - Europe vs. China

Figure 16-11: First Approved Biosimilar - Europe vs. China

Figure 16-12: Approved Biosimilars - Europe vs. Japan

Figure 16-13: First Approved Biosimilar - Europe vs. Japan

Figure 16-14: Biosimilars Approved for Product: Europe vs. Japan

Figure 16-15: Japan – Biosimilar Market Size (US$ Million), 2020-2026

Figure 16-16: Approved Biosimilars - Europe vs. South Korea

Figure 16-17: First Approved Biosimilar - Europe vs. South Korea

Figure 17-1: Europe - Biosimilar Market Favorable Parameters

Figure 17-2: Europe - Biosimilar Market Challenges

Report Title:

Name:

Email address:

Job title:

Organisation:

Contact number:

Country:

Payment Request

Report Title:

Name:

Email address:

Job title:

Organisation:

Contact number:

Country:

Accept Terms & Conditions And Privacy Policy

Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026

Buy USD 20,000 Worth Of Reports (Single User/Multi User License) In USD 8000 Only

Need custom market research solution? We can help you with that too.

About us

Quick links

Contact us

Stay Connected